best performing large cap stock november 2013 to 2015

Neurocrine Biosciences (NBIX) had the highest return between November 1, 2013 and December 31, 2015 by a large-cap US stock, returning 499.3%.

ASSETDATE% RETURN
Neurocrine Biosciences (NBIX)
11/1/2013 - 12/31/2015
499.26%
Celsius (CELH)
11/1/2013 - 12/31/2015
424.49%
Palo Alto Networks (PANW)
11/1/2013 - 12/31/2015
318.19%
Broadcom (AVGO)
11/1/2013 - 12/31/2015
227.38%
Genmab A-S (GMAB)
11/1/2013 - 12/31/2015
203.76%
Skyworks Solutions (SWKS)
11/1/2013 - 12/31/2015
201.92%
Coca-Cola Consolidated (COKE)
11/1/2013 - 12/31/2015
194.8%
DexCom (DXCM)
11/1/2013 - 12/31/2015
185.86%
NetEase (NTES)
11/1/2013 - 12/31/2015
178.93%
Incyte (INCY)
11/1/2013 - 12/31/2015
177.79%
Electronic Arts (EA)
11/1/2013 - 12/31/2015
161.89%
Monster Beverage (MNST)
11/1/2013 - 12/31/2015
158.84%
Southwest Airlines (LUV)
11/1/2013 - 12/31/2015
153.59%
Royal Caribbean Cruises (RCL)
11/1/2013 - 12/31/2015
150.04%
Manhattan Associates (MANH)
11/1/2013 - 12/31/2015
148.9%
Netflix (NFLX)
11/1/2013 - 12/31/2015
143.49%
Edwards Lifesciences (EW)
11/1/2013 - 12/31/2015
141.38%
MACOM Technology Solutions (MTSI)
11/1/2013 - 12/31/2015
137.18%
Centene (CNC)
11/1/2013 - 12/31/2015
135.2%
Acuity Brands (AYI)
11/1/2013 - 12/31/2015
134.49%
NVIDIA (NVDA)
11/1/2013 - 12/31/2015
124.52%
Constellation Brands Inc Class A (STZ)
11/1/2013 - 12/31/2015
119.27%
Global Payments (GPN)
11/1/2013 - 12/31/2015
116.95%
Expedia (EXPE)
11/1/2013 - 12/31/2015
114.66%
AerCap (AER)
11/1/2013 - 12/31/2015
112.61%
Large-cap stocks are treated as having a market cap of $10B+.